“Progression Of Geographic Atrophy And Genotype In Age-Related Macular Degeneration.”. Ophthalmology 117 (8). Ophthalmology: 1554-9, 1559.e1. doi:10.1016/j.ophtha.2009.12.012.
. 2010. “Treatment Of Geographic Atrophy By The Topical Administration Of Ot-551: Results Of A Phase Ii Clinical Trial.”. Invest Ophthalmol Vis Sci 51 (12). Invest Ophthalmol Vis Sci: 6131-9. doi:10.1167/iovs.10-5637.
. 2010. “Risk Factors Associated With Incident Cataracts And Cataract Surgery In The Age-Related Eye Disease Study (Areds): Areds Report Number 32.”. Ophthalmology 118 (11). Ophthalmology: 2113-9. doi:10.1016/j.ophtha.2011.03.032.
. 2011. “The Age-Related Eye Disease Study 2 (Areds2): Study Design And Baseline Characteristics (Areds2 Report Number 1).”. Ophthalmology 119 (11). Ophthalmology: 2282-9. doi:10.1016/j.ophtha.2012.05.027.
. 2012. “"en Face" Oct Imaging Of The Is/os Junction Line In Type 2 Idiopathic Macular Telangiectasia.”. Invest Ophthalmol Vis Sci 53 (10). Invest Ophthalmol Vis Sci: 6145-52. doi:10.1167/iovs.12-10580.
. 2012. “The Is/os Junction Layer In The Natural History Of Type 2 Idiopathic Macular Telangiectasia.”. Invest Ophthalmol Vis Sci 53 (12). Invest Ophthalmol Vis Sci: 7889-95. doi:10.1167/iovs.12-10765.
. 2012. “Longitudinal Analysis Of Retinal Hemangioblastomatosis And Visual Function In Ocular Von Hippel-Lindau Disease.”. Ophthalmology 119 (12). Ophthalmology: 2622-30. doi:10.1016/j.ophtha.2012.06.026.
. 2012. “Spatial Correlation Between Hyperpigmentary Changes On Color Fundus Photography And Hyperreflective Foci On Sdoct In Intermediate Amd.”. Invest Ophthalmol Vis Sci 53 (8). Invest Ophthalmol Vis Sci: 4626-33. doi:10.1167/iovs.12-9813.
. 2012. “Evaluation Of Optimized Digital Fundus Reflex Photographs For Lens Opacities In The Age-Related Eye Disease Study 2: Areds2 Report 7.”. Invest Ophthalmol Vis Sci 54 (9). Invest Ophthalmol Vis Sci: 5989-94. doi:10.1167/iovs.13-12301.
. 2013. “Long-Term Effects Of Vitamins C And E, Β-Carotene, And Zinc On Age-Related Macular Degeneration: Areds Report No. 35.”. Ophthalmology 120 (8). Ophthalmology: 1604-11.e4. doi:10.1016/j.ophtha.2013.01.021.
. 2013. “Medical Characteristics Of Patients With Macular Telangiectasia Type 2 (Mactel Type 2) Mactel Project Report No. 3.”. Ophthalmic Epidemiol 20 (2). Ophthalmic Epidemiol: 109-13. doi:10.3109/09286586.2013.766757.
. 2013. “Methods And Reproducibility Of Grading Optimized Digital Color Fundus Photographs In The Age-Related Eye Disease Study 2 (Areds2 Report Number 2).”. Invest Ophthalmol Vis Sci 54 (7). Invest Ophthalmol Vis Sci: 4548-54. doi:10.1167/iovs.13-11804.
. 2013. “Spectral-Domain Optical Coherence Tomography Characteristics Of Intermediate Age-Related Macular Degeneration.”. Ophthalmology 120 (1). Ophthalmology: 140-50. doi:10.1016/j.ophtha.2012.07.004.
. 2013. “Ten-Year Incidence Rates Of Age-Related Cataract In The Age-Related Eye Disease Study (Areds): Areds Report No. 33.”. Ophthalmic Epidemiol 20 (2). Ophthalmic Epidemiol: 71-81. doi:10.3109/09286586.2012.759598.
. 2013. “Treatment Of Geographic Atrophy With Subconjunctival Sirolimus: Results Of A Phase I/ii Clinical Trial.”. Invest Ophthalmol Vis Sci 54 (4). Invest Ophthalmol Vis Sci: 2941-50. doi:10.1167/iovs.13-11650.
. 2013. “Effect Of Long-Chain Ω-3 Fatty Acids And Lutein + Zeaxanthin Supplements On Cardiovascular Outcomes: Results Of The Age-Related Eye Disease Study 2 (Areds2) Randomized Clinical Trial.”. Jama Intern Med 174 (5). Jama Intern Med: 763-71. doi:10.1001/jamainternmed.2014.328.
. 2014. “Experimental Design Issue For Assessment Of Carotenoids Lutein And Zeaxanthin In Age-Related Eye Disease Study 2 Formulation For Age-Related Macular Degeneration--Reply.”. Jama Ophthalmol 132 (7). Jama Ophthalmol: 904-5. doi:10.1001/jamaophthalmol.2014.1783.
. 2014. “Intravitreal Sirolimus For The Treatment Of Geographic Atrophy: Results Of A Phase I/ii Clinical Trial.”. Invest Ophthalmol Vis Sci 56 (1). Invest Ophthalmol Vis Sci: 330-8. doi:10.1167/iovs.14-15877.
. 2014. “No Clinically Significant Association Between Cfh And Arms2 Genotypes And Response To Nutritional Supplements: Areds Report Number 38.”. Ophthalmology 121 (11). Ophthalmology: 2173-80. doi:10.1016/j.ophtha.2014.05.008.
. 2014. “Randomized Trial Of A Home Monitoring System For Early Detection Of Choroidal Neovascularization Home Monitoring Of The Eye (Home) Study.”. Ophthalmology 121 (2). Ophthalmology: 535-44. doi:10.1016/j.ophtha.2013.10.027.
. 2014. “Randomized Trial Of The Foreseehome Monitoring Device For Early Detection Of Neovascular Age-Related Macular Degeneration. The Home Monitoring Of The Eye (Home) Study Design - Home Study Report Number 1.”. Contemp Clin Trials 37 (2). Contemp Clin Trials: 294-300. doi:10.1016/j.cct.2014.02.003.
. 2014. “Secondary Analyses Of The Effects Of Lutein/zeaxanthin On Age-Related Macular Degeneration Progression: Areds2 Report No. 3.”. Jama Ophthalmol 132 (2). Jama Ophthalmol: 142-9. doi:10.1001/jamaophthalmol.2013.7376.
. 2014. “Ten-Year Follow-Up Of Age-Related Macular Degeneration In The Age-Related Eye Disease Study: Areds Report No. 36.”. Jama Ophthalmol 132 (3). Jama Ophthalmol: 272-7. doi:10.1001/jamaophthalmol.2013.6636.
. 2014. “Visual Acuity After Cataract Surgery In Patients With Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 5.”. Ophthalmology 121 (6). Ophthalmology: 1229-36. doi:10.1016/j.ophtha.2013.12.035.
. 2014. “The Association Of Dietary Lutein Plus Zeaxanthin And B Vitamins With Cataracts In The Age-Related Eye Disease Study: Areds Report No. 37.”. Ophthalmology 122 (7). Ophthalmology: 1471-9. doi:10.1016/j.ophtha.2015.04.007.
. 2015.